OraSure Technologies (OSUR) Getting Somewhat Favorable News Coverage, Analysis Finds
Media coverage about OraSure Technologies (NASDAQ:OSUR) has been trending somewhat positive on Monday, according to Accern Sentiment. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. OraSure Technologies earned a media sentiment score of 0.18 on Accern’s scale. Accern also gave media headlines about the medical instruments supplier an impact score of 45.8860717337597 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Here are some of the media headlines that may have impacted Accern’s rankings:
- OraSure Technologies (OSUR) Stock Rating Reaffirmed by Canaccord Genuity (americanbankingnews.com)
- OraSure Technologies (OSUR) Names Aradhana Sarin M.D. to Board (streetinsider.com)
- What Analyst Recommend? OraSure Technologies, Inc. (OSUR) stock is worth at $21.90 – Nasdaq Fortune (press release) (nasdaqfortune.com)
- OraSure Technologies (OSUR) Names Aradhana Sarin M.D. to Board – StreetInsider.com (streetinsider.com)
- OraSure Technologies Appoints Aradhana Sarin, M.D. to Board of Directors (finance.yahoo.com)
OraSure Technologies (NASDAQ OSUR) opened at $21.55 on Monday. OraSure Technologies has a twelve month low of $8.70 and a twelve month high of $23.01. The firm has a market cap of $1,310.00, a PE ratio of 41.44, a price-to-earnings-growth ratio of 4.83 and a beta of 1.42.
In other OraSure Technologies news, Director Mara G. Aspinall bought 5,000 shares of the company’s stock in a transaction on Tuesday, November 7th. The stock was purchased at an average cost of $14.23 per share, for a total transaction of $71,150.00. Following the acquisition, the director now owns 5,000 shares of the company’s stock, valued at approximately $71,150. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 6.40% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.watchlistnews.com/orasure-technologies-osur-getting-somewhat-favorable-news-coverage-analysis-finds-2/1844993.html.
OraSure Technologies Company Profile
OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.